XBiotech Inc. – NASDAQ:XBIT
Founder-led company
XBiotech stock price today
$3.15
-0.64
-17.11%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 4 hours
XBiotech stock price monthly change
-38.91%
month
XBiotech stock price quarterly change
-38.91%
quarter
XBiotech stock price yearly change
-5.00%
year
XBiotech key metrics
Market Cap | 132.16M |
Enterprise value | N/A |
P/E | -3.26 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 18.39 |
Price/Book | 0.46 |
PEG ratio | 0.03 |
EPS | -1.01 |
Revenue | N/A |
EBITDA | -39.74M |
Income | -30.74M |
Revenue Q/Q | N/A |
Revenue Y/Y | -25.35% |
Profit margin | -826.8% |
Oper. margin | -901.14% |
Gross margin | 82.27% |
EBIT margin | -901.14% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeXBiotech stock price history
XBiotech stock forecast
XBiotech financial statements
| Jun 2023 | 0 | -8.74M | |
|---|---|---|---|
| Sep 2023 | 0 | -7.36M | |
| Dec 2023 | 2.62M | -4.63M | -176.91% |
| Mar 2024 | 0 | -10.00M |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | 22.43% |
| 2022 | |
| 2023 |
| Jun 2023 | 235136000 | 6.07M | 2.58% |
|---|---|---|---|
| Sep 2023 | 229599000 | 6.94M | 3.02% |
| Dec 2023 | 227243000 | 8.39M | 3.7% |
| Mar 2024 | 227858000 | 18.57M | 8.15% |
| Jun 2023 | -8.99M | -208K | 9.20M |
|---|---|---|---|
| Sep 2023 | -1.48M | 61.82M | 5K |
| Dec 2023 | -3.43M | -115K | -9.22M |
| Mar 2024 | -7.20M | -255K | 10.05M |
XBiotech alternative data
| Aug 2023 | 84 |
|---|---|
| Sep 2023 | 84 |
| Oct 2023 | 84 |
| Nov 2023 | 84 |
| Dec 2023 | 85 |
| Jan 2024 | 85 |
| Feb 2024 | 85 |
| Mar 2024 | 82 |
| Apr 2024 | 82 |
| May 2024 | 82 |
| Jun 2024 | 82 |
| Jul 2024 | 92 |
XBiotech other data
2.83%
-6.35%
of XBIT is owned by hedge funds
20
-20
861.18K
-1.89M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 2470355 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SIMARD JOHN director, 10 perc.. | Convertible Loan Agreement | 2,470,355 | $4.05 | $9,999,997 | ||
Option | MCKENZIE W THORPE director, 10 percent owner | Stock Option | 250,000 | $10 | $2,500,000 | ||
Option | MCKENZIE W THORPE director, 10 percent owner | Common Stock | 250,000 | $10 | $2,500,000 | ||
Sale | SIMARD JOHN director, 10 perc.. | Common Stock | 21,125 | $12.9 | $272,534 | ||
Sale | SIMARD JOHN director, 10 perc.. | Common Stock | 10,875 | $12.83 | $139,526 | ||
Sale | SIMARD JOHN director, 10 perc.. | Common Stock | 18,000 | $12.77 | $229,932 | ||
Sale | SIMARD JOHN director, 10 perc.. | Common Stock | 39,286 | $12.45 | $489,111 | ||
Sale | SIMARD JOHN director, 10 perc.. | Common Stock | 10,714 | $12.53 | $134,257 | ||
Sale | SIMARD JOHN director, 10 perc.. | Common Stock | 14,218 | $12.66 | $180,057 | ||
Sale | SIMARD JOHN director, 10 perc.. | Common Stock | 23,681 | $13.09 | $309,866 |
| Patent |
|---|
Application Filling date: 15 Apr 2022 Issue date: 11 Aug 2022 |
Application Filling date: 28 Jun 2018 Issue date: 21 Jan 2021 |
Application Filling date: 8 Jan 2020 Issue date: 30 Apr 2020 |
Application Filling date: 19 Nov 2019 Issue date: 5 Mar 2020 |
Application Filling date: 14 Aug 2019 Issue date: 26 Dec 2019 |
Application Filling date: 2 Aug 2019 Issue date: 21 Nov 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2017 7 May 2017 | Q1 2017 Earnings Call Transcript |
| Q4 2016 16 Mar 2017 | Q4 2016 Earnings Call Transcript |
| Q3 2016 15 Nov 2016 | Q3 2016 Earnings Call Transcript |
| Q2 2016 16 Aug 2016 | Q2 2016 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. John Simard (1962) Founder, Pres, Chief Executive Officer & Chairman | $3,420,000 |
| Dr. Sushma Shivaswamy (1978) Chief Scientific Officer | $456,240 |
Ms. Queena Han CPA, B.A., CPA, C.G.A. (1967) Vice President of Fin. & HR and Sec. | $358,250 |
Friday, 27 December 2024 | ||
| XBIT ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by XBiotech Inc. | accesswire.com | |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT | prnewswire.com | |
Tuesday, 18 June 2024 | ||
| What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday? | benzinga.com | |
| XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer | globenewswire.com | |
Friday, 24 May 2024 | ||
| XBiotech: Several Shots On Goal In Big Target Market Indications | seekingalpha.com | |
Thursday, 7 March 2024 | ||
| Don't Know Much Biology? Tips for Picking Microcap Biotech, Pharma | Zacks Investment Research | |
Thursday, 28 April 2022 | ||
| Why Are XBiotech Shares Trading Higher Today | Benzinga |
-
What's the price of XBiotech stock today?
One share of XBiotech stock can currently be purchased for approximately $3.15.
-
When is XBiotech's next earnings date?
Unfortunately, XBiotech's (XBIT) next earnings date is currently unknown.
-
Does XBiotech pay dividends?
No, XBiotech does not pay dividends.
-
How much money does XBiotech make?
XBiotech has a market capitalization of 132.16M.
-
What is XBiotech's stock symbol?
XBiotech Inc. is traded on the NASDAQ under the ticker symbol "XBIT".
-
What is XBiotech's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of XBiotech?
Shares of XBiotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are XBiotech's key executives?
XBiotech's management team includes the following people:
- Mr. John Simard Founder, Pres, Chief Executive Officer & Chairman(age: 63, pay: $3,420,000)
- Dr. Sushma Shivaswamy Chief Scientific Officer(age: 47, pay: $456,240)
- Ms. Queena Han CPA, B.A., CPA, C.G.A. Vice President of Fin. & HR and Sec.(age: 58, pay: $358,250)
-
Is XBiotech founder-led company?
Yes, XBiotech is a company led by its founder Mr. John Simard.
-
How many employees does XBiotech have?
As Jul 2024, XBiotech employs 92 workers, which is 12% more then previous month and 12% more then previous quarter.
-
When XBiotech went public?
XBiotech Inc. is publicly traded company for more then 10 years since IPO on 15 Apr 2015.
-
What is XBiotech's official website?
The official website for XBiotech is xbiotech.com.
-
Where are XBiotech's headquarters?
XBiotech is headquartered at 5217 Winnebago Lane, Austin, TX.
-
How can i contact XBiotech?
XBiotech's mailing address is 5217 Winnebago Lane, Austin, TX and company can be reached via phone at +51 23862900.
XBiotech company profile:
XBiotech Inc.
xbiotech.comExchange:
NASDAQ
Full time employees:
82
Industry:
Biotechnology
Sector:
Healthcare
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
5217 Winnebago Lane
Austin, TX 78744
Austin, TX 78744
CIK: 0001626878
ISIN: CA98400H1029
CUSIP: 98400H102
